mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
0.14 |
0.5 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.5 |